Retaglutide and tirzepatide are newer GLP-1 receptor agonists gaining popularity as effective treatment options for type 2 diabetes. These medications stimulate insulin secretion from the pancreas, inhibit glucagon https://lewysnugx590961.wikicorrespondence.com/6080696/emerging_therapies_for_type_2_diabetes